Ticker
VEROCompany Name
VENUS CONCEPT INCSector
HealthcareIndustry
Medical DevicesExchange
NASDAQDate | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -32.23M | -53.62% | $ 60.11M |
3/31/2025 | $ -39.22M | -64.3% | $ 61M |
12/31/2024 | $ -36.83M | -56.81% | $ 64.83M |
9/30/2024 | $ -38.16M | -56.79% | $ 67.2M |
6/30/2024 | $ -38.26M | -54.81% | $ 69.81M |
3/31/2024 | $ -26.52M | -36.18% | $ 73.3M |
12/31/2023 | $ -26.31M | -34.46% | $ 76.35M |
9/30/2023 | $ -26.5M | -32.12% | $ 82.51M |
6/30/2023 | $ -32.19M | -37.25% | $ 86.43M |
3/31/2023 | $ -35.98M | -38.43% | $ 93.62M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA / Revenues
(=) EBITDA %
EBITDA % for VENUS CONCEPT INC is calculated as follows: EBITDA [ $ -69.07M ] / Revenues [ $ 150.96M ]
(=) EBITDA % [ -45.76% ]
Minimum
Dec 31, 2020
Maximum
Mar 31, 2022
Average
Median
filtered constituents | 3.29K |
---|---|
min | -75.07% |
max | 97.73% |
average | 16.12% |
median | 14.72% |
std | 26.88% |